PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 60 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

20 November 2024

  1. (diff | hist) m 00:41 Contract development and manufacturing organisation 2,252 ±0 SupplyWatchSuri (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]

19 November 2024

  1. (diff | hist) 23:52 Liquid chromatography-mass spectrometry 2,642 ±0 ForgeryFinder (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) 20:07 Medutest 2,738 ±0 GroupBuyGalen (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  3. (diff | hist) 19:41 Haemoglobin A1c 2,610 +36 DrTitration (talk | contribs) de-orphan [rollback]
  4. (diff | hist) 16:23 Baseline laboratory panel 2,304 +357 BaselineBex (talk | contribs) expand §Common components [rollback]
  5. (diff | hist) 14:45 Placebo-adjusted effect 2,853 +696 TriumphThad (talk | contribs) fix a dangling clause [rollback]
  6. (diff | hist) 12:15 Talk:Beyond-use date 748 +323 Compounding_Cate (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  7. (diff | hist) 09:53 Reverse-phase HPLC 3,742 +697 TechnicianTeal (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  8. (diff | hist) 09:38 Talk:Beyond-use date 537 +332 FiveOhThreeA (talk | contribs) /* The 25% rule keeps being reinstated */ new section
  9. (diff | hist) 09:37 Talk:Tianjin Finder Chemical 822 +169 RepackRadek (talk | contribs) /* Manufacturer or distributor? */ reply
  10. (diff | hist) 09:33 Insulin secretion 4,409 +469 LCellLeif (talk | contribs) expand §The triggering pathway [rollback]
  11. (diff | hist) N 09:00 Melanotan II 1,177 +1,177 ITT_Imelda (talk | contribs) start article; sequence and sourcing only so far
  12. (diff | hist) m 06:34 Contraindications of incretin therapy 2,065 ±0 NAION_Noel (talk | contribs) add the rebound point with the follow-up study it comes from [rollback]
  13. (diff | hist) 04:14 USP General Chapter 85 2,668 +582 OffLabelOdile (talk | contribs) British spelling per PP:MOS [rollback]
  14. (diff | hist) m 04:08 Underfilling 1,108 ±0 Chromatokid (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  15. (diff | hist) m 03:58 Qingdao Sigma Chemical 5,668 +386 SharpsSukhi (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  16. (diff | hist) 00:43 Triple agonist 2,546 ±0 EndpointEnid (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  17. (diff | hist) 00:27 Resin cleavage 2,920 +557 ColdChainCleo (talk | contribs) correct the eutectic temperature — source gives a range [rollback]

18 November 2024

  1. (diff | hist) 21:53 Vial 12,879 +1,702 RepackRadek (talk | contribs) add the collapse-temperature point, sourced [rollback]
  2. (diff | hist) 14:26 Talk:Tianjin Finder Chemical 611 +290 Hedgerow_Hal (talk | contribs) /* Manufacturer or distributor? */ reply
  3. (diff | hist) 14:23 Guangzhou JEEP Biotechnology 7,661 +477 LedgerLysander (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) m 14:11 International nonproprietary name 2,063 +230 SeeAlsoSelma (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  5. (diff | hist) 14:04 Blind sampling 3,727 +33 EndotoxinEd (talk | contribs) convert a hard-coded date to the house format [rollback]
  6. (diff | hist) 12:42 Tianjin Finder Chemical 3,076 +343 GroupBuyGalen (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  7. (diff | hist) m 11:24 Peptide supply chain 3,539 ±0 CDMO_Caradoc (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  8. (diff | hist) 10:52 Talk:Tianjin Finder Chemical 400 +283 CDMO_Caradoc (talk | contribs) /* Manufacturer or distributor? */ new section
  9. (diff | hist) 09:36 Peptide synthesis 3,621 +583 ColdChainCleo (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  10. (diff | hist) 09:06 Reference standard 3,644 +772 Areapercent_Ayo (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  11. (diff | hist) N 09:00 Amino acid analysis 2,043 +2,043 LedgerLysander (talk | contribs) create article — method stub
  12. (diff | hist) m 03:29 Injection site rotation 2,929 ±0 GMP_Gita (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  13. (diff | hist) m 01:58 Amylin 3,238 +34 VerifyVesna (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  14. (diff | hist) m 01:43 Methionine oxidation 2,072 +656 PuffRemoverPax (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]

17 November 2024

  1. (diff | hist) m 23:17 Test report forgery 2,319 +321 BaselineBex (talk | contribs) expand §Internal signals [rollback]
  2. (diff | hist) m 11:11 Dual incretin agonist 3,465 +113 GroupBuyGalen (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  3. (diff | hist) 09:42 Shanghai Sigma-Audley New Material Technology 2,709 +363 LotTraceLuka (talk | contribs) state what the certificate supplied with orders carries [rollback]
  4. (diff | hist) 08:32 Wuhan Wansheng Biotechnology 7,760 +308 ForgeryFinder (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  5. (diff | hist) 04:42 Intention-to-treat analysis 3,316 +625 TriumphThad (talk | contribs) add the trial acronym expansion at first use [rollback]
  6. (diff | hist) m b 01:30 Receptor bias 2,387 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 00:43 Glucagon-like peptide-1 8,227 +341 SatietySunniva (talk | contribs) fix hyphenation per PP:MOS [rollback]

16 November 2024

  1. (diff | hist) 22:20 Third-party testing 4,926 +481 EndpointEnid (talk | contribs) state the date range the submitted set covers [rollback]
  2. (diff | hist) m 21:47 Tirzepatide 5,120 +131 OralSemaOswin (talk | contribs) fix the anchor on an internal link [rollback]
  3. (diff | hist) 20:58 Bachem Holding (Suzhou) 4,637 +1,302 Chromatokid (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  4. (diff | hist) 16:57 Missed dose 3,140 +30 DrTitration (talk | contribs) fix hyphenation per PP:MOS [rollback]
  5. (diff | hist) m 16:51 Aspiration risk under anaesthesia 2,646 +387 AnalyticalAnnie (talk | contribs) clarify that dose-dependence is reported for some effects and not others [rollback]
  6. (diff | hist) 16:33 Electrospray ionisation 2,601 +34 TrialsTabitha (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) 14:16 Dose escalation schedule 2,719 +500 CarryOverCai (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  8. (diff | hist) 13:01 Dulaglutide 3,106 ±0 ParentCatPansy (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  9. (diff | hist) m b 10:14 Lyophilisation 10,259 +907 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  10. (diff | hist) 07:50 Amylin receptor agonist 2,571 +35 ParentCatPansy (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  11. (diff | hist) 02:03 Lot traceability 2,794 ±0 Chromatokid (talk | contribs) fix the anchor on an internal link [rollback]

15 November 2024

  1. (diff | hist) 23:35 Semaglutide 6,658 +1,050 ColdChainCleo (talk | contribs) expand §Chemistry and engineering [rollback]
  2. (diff | hist) m 19:30 Solid-phase peptide synthesis 3,861 +484 PreregPriya (talk | contribs) expand §Difficult sequences [rollback]
  3. (diff | hist) 19:10 Beta cell function 3,162 ±0 MTC_Marisol (talk | contribs) distinguish the active and total forms of the hormone throughout [rollback]
  4. (diff | hist) m 12:26 Proglucagon 3,465 +27 IncretinIvo (talk | contribs) close an unbalanced quotation mark [rollback]
  5. (diff | hist) m 11:04 Repackaging 2,904 +444 FreightFenna (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  6. (diff | hist) N 09:00 Customs seizure 1,052 +1,052 FiveOhThreeA (talk | contribs) create article — regulatory stub
  7. (diff | hist) 02:02 Insulin syringe 2,889 +99 DrTitration (talk | contribs) add the cross-link to the calculator page [rollback]

14 November 2024

  1. (diff | hist) m 22:09 Chain of custody 2,966 ±0 TrialsTabitha (talk | contribs) correct the description of the sampling procedure [rollback]
  2. (diff | hist) 19:59 USP General Chapter 71 1,714 ±0 DrTitration (talk | contribs) typo [rollback]
  3. (diff | hist) 18:23 Peptide aggregation 3,043 +356 TFA_Counterion (talk | contribs) clarify that area percent is not mass percent [rollback]
  4. (diff | hist) 17:33 Batch number 2,982 +488 UnderfillUna (talk | contribs) ce, tighten prose [rollback]
  5. (diff | hist) m 11:56 HOMA-IR 2,317 +32 UACR_Ulric (talk | contribs) add the note that a single value out of range is not a finding [rollback]
  6. (diff | hist) 11:47 Talk:Peptide content 1,033 +60 AAA_Analyst (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  7. (diff | hist) 07:59 ChinaPeptides 2,939 ±0 IsocraticIla (talk | contribs) split §Operations from §Product range [rollback]
  8. (diff | hist) 07:53 Custom peptide synthesis 2,690 +283 MelanocortinMil (talk | contribs) add the collapse-temperature point, sourced [rollback]
  9. (diff | hist) 00:25 Timeline of incretin therapeutics 2,352 ±0 DulaglutideDug (talk | contribs) expand §Physiology [rollback]

13 November 2024

  1. (diff | hist) m 23:35 Certificate of analysis 5,485 ±0 ForgeryFinder (talk | contribs) expand §The fields most often missing [rollback]
  2. (diff | hist) m b 21:16 Adverse effects of GLP-1 receptor agonists 3,171 +34 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) 20:03 Fmoc chemistry 3,388 +40 PrepHPLC_Pia (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) 17:40 Karl Fischer titration 5,150 +184 ChromCleanupCass (talk | contribs) expand §Volumetric and coulometric variants [rollback]
  5. (diff | hist) m b 17:37 Chinese Peptide Company 5,897 ±0 StubSorterBot (talk | contribs) bot: add supplier category [rollback]
  6. (diff | hist) 16:49 Good manufacturing practice 2,501 +29 DeadSpaceDot (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) 16:39 Residual solvent 2,880 ±0 SigFigSindri (talk | contribs) fix a broken wikilink [rollback]
  8. (diff | hist) 15:14 Body composition assessment 1,910 +775 HOMA_Hettie (talk | contribs) typo [rollback]
  9. (diff | hist) 09:02 Talk:Peptide content 822 +177 KarlFischerKit (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  10. (diff | hist) m b 07:50 Growth hormone secretagogue 1,842 ±0 ArchiveBot (talk | contribs) bot: add stub category [rollback]

12 November 2024

  1. (diff | hist) 19:52 Arcuate nucleus 3,033 +333 GsCouplingGil (talk | contribs) add the cleavage site by residue number [rollback]
  2. (diff | hist) 19:20 Nantong Guangyuan Chemical 6,450 +201 PeakShapePol (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  3. (diff | hist) 14:36 Talk:Peptide content 611 +241 TFA_Counterion (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  4. (diff | hist) 14:11 Oral semaglutide 2,537 ±0 CRP_Cormac (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) 13:52 Reconstitution of lyophilised peptides 3,118 ±0 DeadSpaceDot (talk | contribs) give the worked example to two significant figures throughout [rollback]
  6. (diff | hist) m b 13:31 Area percent purity 3,599 +221 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) 10:50 Drug master file 1,789 +238 ImportRecordIna (talk | contribs) sentence case in headings per PP:MOS [rollback]
  8. (diff | hist) m 10:30 Deamidation 2,020 ±0 ResolutionRoo (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  9. (diff | hist) 10:23 Cold-chain freight 2,114 +214 DiluentDiya (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  10. (diff | hist) 10:19 Talk:Peptide content 400 +209 AAA_Analyst (talk | contribs) /* Typical content range: is 70–90% defensible? */ new section
  11. (diff | hist) N 09:00 Underfilling 1,108 +1,108 GastroparesisGwen (talk | contribs) create article — testing stub
  12. (diff | hist) m 06:54 Baseline laboratory panel 1,947 ±0 Compounding_Cate (talk | contribs) state whether the figure is a mean or a median [rollback]
  13. (diff | hist) m 06:23 Number needed to treat 2,280 +296 ForestPlotFinn (talk | contribs) copyedit [rollback]
  14. (diff | hist) 05:29 Peptide 4,033 +130 PrepHPLC_Pia (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  15. (diff | hist) 04:45 Crude peptide 2,632 ±0 CounterfeitCato (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]

11 November 2024

  1. (diff | hist) 22:25 Contract development and manufacturing organisation 2,252 +925 SPPS_Sorrel (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  2. (diff | hist) m 22:03 TRIUMPH trial programme 2,837 +357 NeutralNikolai (talk | contribs) add the year of publication to each trial in the list [rollback]
  3. (diff | hist) 19:52 Limit of detection 3,509 +920 IsocraticIla (talk | contribs) sentence case in headings per PP:MOS [rollback]
  4. (diff | hist) m 17:15 Hunan Aslsen Technology 4,912 +641 HyphenHarriet (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  5. (diff | hist) 13:19 Beyond-use date 4,878 +614 LedeLeander (talk | contribs) expand §Opened containers [rollback]
  6. (diff | hist) 11:14 Contraindications of incretin therapy 2,065 +588 ClinicCorrespondent (talk | contribs) fix a dangling clause [rollback]
  7. (diff | hist) 10:52 Mass spectrometry 3,881 +41 Chromatokid (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  8. (diff | hist) N 10:38 Body composition assessment 1,135 +1,135 PlainNumbersPip (talk | contribs) create article — laboratory stub
  9. (diff | hist) 10:26 Methionine oxidation 1,416 ±0 ColumnOvenCoy (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]